Diabetic cardiomyopathy-a comprehensive updated review

G Murtaza, HUH Virk, M Khalid, CJ Lavie… - Progress in …, 2019 - Elsevier
Diabetes causes cardiomyopathy and increases the risk of heart failure independent of
hypertension and coronary heart disease. This condition called “Diabetic Cardiomyopathy” …

Regulation of cardiac hypertrophy by intracellular signalling pathways

J Heineke, JD Molkentin - Nature reviews Molecular cell biology, 2006 - nature.com
The mammalian heart is a dynamic organ that can grow and change to accommodate
alterations in its workload. During development and in response to physiological stimuli or …

The incidence of congestive heart failure in type 2 diabetes: an update

GA Nichols, CM Gullion, CE Koro, SA Ephross… - Diabetes …, 2004 - Am Diabetes Assoc
OBJECTIVE—The aims of this study were to update previous estimates of the congestive
heart failure (CHF) incidence rate in patients with type 2 diabetes, compare it with an age …

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors

GA Nichols, TA Hillier, JR Erbey, JB Brown - Diabetes care, 2001 - Am Diabetes Assoc
OBJECTIVE—To estimate the prevalence and incidence of congestive heart failure (CHF) in
populations with and without type 2 diabetes and to identify risk factors for diabetes …

Hypertension and cardiac arrhythmias: a consensus document from the European heart rhythm association (EHRA) and ESC Council on hypertension, endorsed by …

GYH Lip, A Coca, T Kahan, G Boriani, AS Manolis… - Ep …, 2017 - academic.oup.com
Hypertension is a common cardiovascular risk factor leading to heart failure (HF), coronary
artery disease, stroke, peripheral artery disease and chronic renal insufficiency …

Prevention of heart failure: a scientific statement from the American Heart Association Councils on epidemiology and prevention, clinical cardiology, cardiovascular …

DD Schocken, EJ Benjamin, GC Fonarow… - Circulation, 2008 - Am Heart Assoc
The increase in heart failure (HF) rates throughout the developed and developing regions of
the world poses enormous challenges for caregivers, researchers, and policymakers …

Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1

S Rosenkranz, M Flesch, K Amann… - American Journal …, 2002 - journals.physiology.org
Transforming growth factor-β1 (TGF-β1) promotes or inhibits cell proliferation and induces
fibrotic processes and extracellular matrix production in numerous cell types. Several …

Cardiovascular phenotype in Turner syndrome—integrating cardiology, genetics, and endocrinology

KH Mortensen, NH Andersen, CH Gravholt - Endocrine reviews, 2012 - academic.oup.com
Cardiovascular disease is emerging as a cardinal trait of Turner syndrome, being
responsible for half of the 3-fold excess mortality. Turner syndrome has been proposed as …

Diabetes and idiopathic cardiomyopathy: a nationwide case-control study

AG Bertoni, A Tsai, EK Kasper, FL Brancati - Diabetes care, 2003 - Am Diabetes Assoc
OBJECTIVE—Controversy exists regarding the relation between diabetes and nonischemic
idiopathic cardiomyopathy (ICM), and only limited data on the incidence of ICM in adults with …

Autophagy, organelles and ageing

A Terman, B Gustafsson… - The Journal of Pathology: A …, 2007 - Wiley Online Library
As a result of insufficient digestion of oxidatively damaged macromolecules and organelles
by autophagy and other degradative systems, long‐lived postmitotic cells, such as cardiac …